Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 16 | 2021 | 183 | 3.000 |
Why?
|
| Robotic Surgical Procedures | 5 | 2021 | 26 | 2.690 |
Why?
|
| Ureter | 9 | 2020 | 27 | 2.280 |
Why?
|
| Prostatic Neoplasms | 6 | 2021 | 91 | 2.230 |
Why?
|
| Ureteral Calculi | 4 | 2023 | 6 | 1.780 |
Why?
|
| Ureteral Obstruction | 4 | 2018 | 15 | 1.670 |
Why?
|
| Kidney Calculi | 4 | 2019 | 6 | 1.480 |
Why?
|
| Robotics | 5 | 2020 | 20 | 1.430 |
Why?
|
| Nephrectomy | 9 | 2012 | 37 | 1.360 |
Why?
|
| Ureteroscopy | 6 | 2021 | 8 | 1.270 |
Why?
|
| Kidney Pelvis | 3 | 2019 | 12 | 1.210 |
Why?
|
| Kidney Neoplasms | 8 | 2012 | 75 | 1.190 |
Why?
|
| Adipose Tissue | 2 | 2018 | 72 | 1.030 |
Why?
|
| Prostate | 2 | 2016 | 30 | 1.000 |
Why?
|
| Humans | 46 | 2023 | 23331 | 0.960 |
Why?
|
| Lithotripsy | 2 | 2019 | 2 | 0.950 |
Why?
|
| Prostatectomy | 3 | 2021 | 20 | 0.830 |
Why?
|
| Risk Assessment | 6 | 2019 | 565 | 0.810 |
Why?
|
| Kidney Diseases | 2 | 2016 | 69 | 0.790 |
Why?
|
| Carcinoma, Renal Cell | 4 | 2012 | 45 | 0.760 |
Why?
|
| Calculi | 2 | 2019 | 2 | 0.750 |
Why?
|
| Male | 25 | 2023 | 12629 | 0.680 |
Why?
|
| Neoplasm Grading | 2 | 2018 | 53 | 0.650 |
Why?
|
| Intra-Abdominal Fat | 2 | 2018 | 40 | 0.630 |
Why?
|
| Endoscopy | 3 | 2019 | 169 | 0.630 |
Why?
|
| Staghorn Calculi | 1 | 2019 | 1 | 0.610 |
Why?
|
| Nephrotomy | 1 | 2019 | 1 | 0.610 |
Why?
|
| Ureteral Diseases | 2 | 2016 | 3 | 0.610 |
Why?
|
| Urinary Diversion | 2 | 2017 | 3 | 0.590 |
Why?
|
| Cystectomy | 2 | 2017 | 8 | 0.590 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2023 | 593 | 0.590 |
Why?
|
| Postoperative Complications | 4 | 2017 | 836 | 0.580 |
Why?
|
| Creatinine | 1 | 2018 | 40 | 0.580 |
Why?
|
| Renal Artery | 2 | 2017 | 6 | 0.570 |
Why?
|
| Urinary Tract Infections | 2 | 2016 | 31 | 0.570 |
Why?
|
| Nephrolithotomy, Percutaneous | 1 | 2018 | 1 | 0.570 |
Why?
|
| Solitary Kidney | 1 | 2018 | 1 | 0.570 |
Why?
|
| Retrospective Studies | 10 | 2023 | 3040 | 0.570 |
Why?
|
| Aorta, Abdominal | 1 | 2017 | 2 | 0.560 |
Why?
|
| Vascular Malformations | 1 | 2017 | 3 | 0.560 |
Why?
|
| Middle Aged | 14 | 2021 | 8055 | 0.550 |
Why?
|
| Hydronephrosis | 3 | 2018 | 6 | 0.540 |
Why?
|
| Urinary Bladder | 2 | 2017 | 18 | 0.530 |
Why?
|
| Replantation | 2 | 2020 | 9 | 0.530 |
Why?
|
| Urinary Retention | 1 | 2017 | 12 | 0.530 |
Why?
|
| Ileum | 1 | 2017 | 14 | 0.520 |
Why?
|
| Body Mass Index | 3 | 2016 | 384 | 0.510 |
Why?
|
| Candidiasis | 1 | 2016 | 23 | 0.510 |
Why?
|
| Aged | 14 | 2021 | 7552 | 0.500 |
Why?
|
| Kidney Transplantation | 1 | 2017 | 114 | 0.490 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 88 | 0.480 |
Why?
|
| Nephrostomy, Percutaneous | 3 | 2016 | 5 | 0.420 |
Why?
|
| Female | 20 | 2018 | 13124 | 0.410 |
Why?
|
| Kidney Medulla | 1 | 2013 | 1 | 0.400 |
Why?
|
| Nephrolithiasis | 1 | 2013 | 1 | 0.400 |
Why?
|
| Image-Guided Biopsy | 3 | 2018 | 34 | 0.400 |
Why?
|
| Calcinosis | 1 | 2013 | 43 | 0.390 |
Why?
|
| Free Tissue Flaps | 1 | 2011 | 14 | 0.360 |
Why?
|
| Adult | 9 | 2018 | 7070 | 0.330 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2019 | 293 | 0.330 |
Why?
|
| Colic | 1 | 2009 | 1 | 0.320 |
Why?
|
| Pregnancy Complications | 1 | 2009 | 46 | 0.300 |
Why?
|
| Posture | 2 | 2008 | 56 | 0.300 |
Why?
|
| Rhabdomyolysis | 1 | 2008 | 5 | 0.290 |
Why?
|
| Treatment Outcome | 9 | 2019 | 2988 | 0.280 |
Why?
|
| Awards and Prizes | 1 | 2008 | 21 | 0.280 |
Why?
|
| Liver Cirrhosis | 1 | 2008 | 44 | 0.280 |
Why?
|
| Cryosurgery | 4 | 2009 | 16 | 0.270 |
Why?
|
| Sex Characteristics | 1 | 2008 | 86 | 0.270 |
Why?
|
| Skin | 1 | 2008 | 119 | 0.270 |
Why?
|
| Vas Deferens | 1 | 2007 | 1 | 0.270 |
Why?
|
| Granuloma | 1 | 2007 | 13 | 0.270 |
Why?
|
| Genital Diseases, Male | 1 | 2007 | 6 | 0.270 |
Why?
|
| Spermatic Cord | 1 | 2007 | 15 | 0.260 |
Why?
|
| Risk Factors | 5 | 2021 | 1998 | 0.260 |
Why?
|
| Ultrasonography, Interventional | 2 | 2018 | 64 | 0.260 |
Why?
|
| Stents | 3 | 2017 | 77 | 0.260 |
Why?
|
| Sepsis | 1 | 2008 | 112 | 0.260 |
Why?
|
| Ureteroscopes | 2 | 2021 | 2 | 0.240 |
Why?
|
| Incidence | 3 | 2017 | 636 | 0.240 |
Why?
|
| Sutures | 3 | 2010 | 31 | 0.220 |
Why?
|
| Neoplasm Staging | 5 | 2021 | 359 | 0.220 |
Why?
|
| Erectile Dysfunction | 2 | 2021 | 53 | 0.220 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2023 | 2 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 880 | 0.200 |
Why?
|
| Computers | 1 | 2023 | 14 | 0.200 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2017 | 33 | 0.200 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 22 | 0.190 |
Why?
|
| Genomics | 1 | 2021 | 51 | 0.170 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 112 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 113 | 0.170 |
Why?
|
| Regression Analysis | 2 | 2018 | 220 | 0.170 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 3783 | 0.160 |
Why?
|
| Pain, Postoperative | 2 | 2021 | 273 | 0.150 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 1441 | 0.150 |
Why?
|
| Electrosurgery | 2 | 2009 | 5 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 148 | 0.150 |
Why?
|
| Patient Positioning | 1 | 2019 | 34 | 0.150 |
Why?
|
| Color | 1 | 2018 | 7 | 0.150 |
Why?
|
| Monitoring, Intraoperative | 1 | 2019 | 36 | 0.150 |
Why?
|
| Lymph Node Excision | 2 | 2017 | 26 | 0.150 |
Why?
|
| Margins of Excision | 1 | 2018 | 29 | 0.150 |
Why?
|
| Operative Time | 1 | 2019 | 82 | 0.150 |
Why?
|
| Tissue Adhesives | 2 | 2009 | 5 | 0.150 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 210 | 0.140 |
Why?
|
| Feasibility Studies | 1 | 2018 | 210 | 0.140 |
Why?
|
| Acute Disease | 1 | 2018 | 168 | 0.140 |
Why?
|
| Prostate-Specific Antigen | 1 | 2017 | 15 | 0.140 |
Why?
|
| Ultrasonic Therapy | 2 | 2008 | 21 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2018 | 380 | 0.130 |
Why?
|
| Anastomosis, Surgical | 1 | 2017 | 27 | 0.130 |
Why?
|
| Endosonography | 1 | 2016 | 10 | 0.130 |
Why?
|
| Multimodal Imaging | 1 | 2016 | 27 | 0.130 |
Why?
|
| Postoperative Care | 1 | 2017 | 109 | 0.130 |
Why?
|
| Contrast Media | 1 | 2016 | 60 | 0.130 |
Why?
|
| Illinois | 1 | 2016 | 221 | 0.120 |
Why?
|
| Cohort Studies | 2 | 2018 | 1429 | 0.120 |
Why?
|
| Patient Selection | 2 | 2007 | 171 | 0.120 |
Why?
|
| Sus scrofa | 3 | 2010 | 7 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2008 | 204 | 0.120 |
Why?
|
| Reoperation | 1 | 2019 | 776 | 0.120 |
Why?
|
| Radiotherapy | 1 | 2015 | 32 | 0.110 |
Why?
|
| Hysterectomy | 1 | 2015 | 25 | 0.110 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2015 | 33 | 0.110 |
Why?
|
| Equipment Design | 5 | 2021 | 123 | 0.110 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 10 | 0.110 |
Why?
|
| Vitamin D | 1 | 2014 | 28 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 296 | 0.110 |
Why?
|
| Pressure | 3 | 2008 | 50 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 166 | 0.110 |
Why?
|
| Animals | 9 | 2010 | 3287 | 0.100 |
Why?
|
| Models, Animal | 2 | 2010 | 100 | 0.100 |
Why?
|
| Hemostasis | 2 | 2011 | 11 | 0.100 |
Why?
|
| Urothelium | 1 | 2011 | 5 | 0.090 |
Why?
|
| Surgical Instruments | 2 | 2008 | 24 | 0.090 |
Why?
|
| Intraoperative Period | 1 | 2011 | 23 | 0.090 |
Why?
|
| Psoas Muscles | 1 | 2011 | 6 | 0.090 |
Why?
|
| Ureteral Neoplasms | 1 | 2011 | 5 | 0.090 |
Why?
|
| Endometriosis | 1 | 2011 | 15 | 0.090 |
Why?
|
| Iatrogenic Disease | 1 | 2011 | 22 | 0.090 |
Why?
|
| Swine | 5 | 2009 | 67 | 0.090 |
Why?
|
| Wound Healing | 2 | 2009 | 113 | 0.080 |
Why?
|
| Kidney | 2 | 2009 | 142 | 0.080 |
Why?
|
| Alloys | 2 | 2008 | 92 | 0.080 |
Why?
|
| Glutaral | 1 | 2010 | 2 | 0.080 |
Why?
|
| Serum Albumin, Bovine | 1 | 2010 | 5 | 0.080 |
Why?
|
| Length of Stay | 2 | 2008 | 305 | 0.080 |
Why?
|
| Adhesives | 1 | 2009 | 1 | 0.080 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2009 | 5 | 0.080 |
Why?
|
| Thoracic Duct | 1 | 2008 | 3 | 0.070 |
Why?
|
| Pregnancy | 1 | 2009 | 322 | 0.070 |
Why?
|
| Universities | 1 | 2009 | 37 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2009 | 36 | 0.070 |
Why?
|
| Lithotripsy, Laser | 1 | 2008 | 1 | 0.070 |
Why?
|
| Intestines | 1 | 2009 | 76 | 0.070 |
Why?
|
| Teaching Materials | 1 | 2008 | 9 | 0.070 |
Why?
|
| Warm Ischemia | 1 | 2008 | 2 | 0.070 |
Why?
|
| Silicones | 1 | 2008 | 10 | 0.070 |
Why?
|
| Hematocrit | 1 | 2008 | 13 | 0.070 |
Why?
|
| Cystotomy | 1 | 2008 | 1 | 0.070 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2008 | 3 | 0.070 |
Why?
|
| Blood Loss, Surgical | 1 | 2008 | 54 | 0.070 |
Why?
|
| Vagina | 1 | 2008 | 31 | 0.070 |
Why?
|
| o-Phthalaldehyde | 1 | 2007 | 1 | 0.070 |
Why?
|
| Time Factors | 2 | 2008 | 1289 | 0.070 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2007 | 18 | 0.070 |
Why?
|
| Disinfectants | 1 | 2007 | 8 | 0.070 |
Why?
|
| Disinfection | 1 | 2007 | 11 | 0.070 |
Why?
|
| Urodynamics | 1 | 2007 | 3 | 0.070 |
Why?
|
| Retroperitoneal Space | 1 | 2007 | 8 | 0.070 |
Why?
|
| Hernia, Inguinal | 1 | 2007 | 18 | 0.070 |
Why?
|
| Colon | 1 | 2008 | 110 | 0.070 |
Why?
|
| Laser Therapy | 1 | 2006 | 11 | 0.060 |
Why?
|
| Recurrence | 1 | 2007 | 272 | 0.060 |
Why?
|
| Catheter Ablation | 1 | 2006 | 34 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 322 | 0.060 |
Why?
|
| Andropause | 1 | 2005 | 1 | 0.060 |
Why?
|
| Infertility, Male | 1 | 2005 | 6 | 0.060 |
Why?
|
| United States | 2 | 2021 | 1829 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2023 | 50 | 0.050 |
Why?
|
| Prognosis | 2 | 2021 | 740 | 0.050 |
Why?
|
| Immune System | 1 | 2021 | 11 | 0.040 |
Why?
|
| Search Engine | 1 | 2021 | 6 | 0.040 |
Why?
|
| Seasons | 1 | 2021 | 19 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2021 | 68 | 0.040 |
Why?
|
| Internet | 1 | 2021 | 80 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 157 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2010 | 245 | 0.040 |
Why?
|
| Swine, Miniature | 2 | 2009 | 6 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 594 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2014 | 24 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 149 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2007 | 1523 | 0.020 |
Why?
|
| Surveys and Questionnaires | 2 | 2008 | 1038 | 0.020 |
Why?
|
| Nephrons | 1 | 2011 | 6 | 0.020 |
Why?
|
| Electrodes | 1 | 2009 | 14 | 0.020 |
Why?
|
| California | 1 | 2009 | 35 | 0.020 |
Why?
|
| Temperature | 1 | 2009 | 58 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2008 | 18 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2008 | 27 | 0.020 |
Why?
|
| Rabbits | 1 | 2009 | 168 | 0.020 |
Why?
|
| Dissection | 1 | 2008 | 22 | 0.020 |
Why?
|
| Equipment Safety | 1 | 2008 | 6 | 0.020 |
Why?
|
| Holmium | 1 | 2008 | 1 | 0.020 |
Why?
|
| Hemostasis, Surgical | 1 | 2008 | 11 | 0.020 |
Why?
|
| Laboratories | 1 | 2008 | 9 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2009 | 129 | 0.020 |
Why?
|
| Device Removal | 1 | 2009 | 82 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 155 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2008 | 134 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2008 | 93 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 101 | 0.020 |
Why?
|
| Equipment Reuse | 1 | 2007 | 1 | 0.020 |
Why?
|
| Endoscopes | 1 | 2007 | 9 | 0.020 |
Why?
|
| Fiber Optic Technology | 1 | 2007 | 7 | 0.020 |
Why?
|
| Equipment Failure | 1 | 2007 | 35 | 0.020 |
Why?
|
| Equipment Contamination | 1 | 2007 | 25 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2007 | 64 | 0.020 |
Why?
|
| Peritoneum | 1 | 2007 | 16 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2007 | 87 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 338 | 0.020 |
Why?
|
| Pleural Diseases | 1 | 2007 | 2 | 0.020 |
Why?
|
| Punctures | 1 | 2007 | 10 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 452 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 72 | 0.020 |
Why?
|
| Models, Biological | 1 | 2009 | 306 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2008 | 524 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2007 | 43 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 102 | 0.020 |
Why?
|
| Probability | 1 | 2005 | 73 | 0.010 |
Why?
|
| Age Distribution | 1 | 2005 | 71 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 1674 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 167 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2005 | 482 | 0.010 |
Why?
|
| Comorbidity | 1 | 2005 | 431 | 0.010 |
Why?
|
| Obesity | 1 | 2007 | 293 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 813 | 0.010 |
Why?
|